Quick-Med Technologies to Present NIMBUS at the Symposium on Advanced Wound Care and Wound Healing Society Meeting
Gainesville, Florida – April 9, 2009 – Quick-Med Technologies, Inc., an emerging life
sciences company specializing in novel antimicrobial technologies, announced that data
on three of its proprietary antimicrobial technologies is being presented at the 2009
Symposium on Advanced Wound Care and the Wound Healing Society meeting. This
event is the premier annual meeting of physicians, researchers and other wound care
specialists and is being held in Dallas, Texas, on April 26-29, 2009. Quick-Med’s
scientists will present four abstracts at the prestigious meeting.
Two of Quick-Med’s abstracts feature key aspects of the company’s NIMBUS® Barrier
Gauze Dressing, a unique, non-leaching antimicrobial technology that recently received
FDA clearance:
Antimicrobial Wound Dressings: Mechanisms and Function – A profile of the barrier
properties of NIMBUS that substantiates its performance in the presence of wound
exudate while permitting safe and rapid healing without risk of bacterial mutation. It is a
predicate material ready for incorporation into other application formats.
Bacterial Resistance Issues in Wound Care and Wound Dressings – A review of the basic
process that leads to the development of bacterial resistance by various microbicidal
materials and a summary of the test results demonstrating that NIMBUS does not display
this mutation effect
NIMBUS offers improved safety and efficacy. It is unique in that it is a sterile bacterial
barrier that prohibits the transfer of microorganisms into the wound because the
microbicidal agent is irreversibly bound to the dressing. “NIMBUS is the first bound,
antimicrobial material – rather than delivering an antimicrobial into the wound, it creates
a barrier that won’t allow bacteria to penetrate the dressing or grow in the wound fluid,”
says Gregory Schultz, Professor, Institute for Wound Research at the University of
Florida and Past President of the Wound Healing Society. “Traditional wound dressings absorb fluid from the wound and act as a great incubator for bacteria that are shed back
into the wound.”
NIMBUS is non-toxic, long-lasting and not blocked by organics such as blood, urine and
perspiration. Product labeling has been allowed that indicates various organisms such as
MRSA, VRE, Pseudomonas aeruginosa and Escherichia coli are killed at levels
exceeding 99.999%. NIMBUS barrier gauze will be available in June under license from
Quick-Med and will be marketed as BIOGUARD™ by Derma Sciences.
Additional Technologies
Additionally, Quick-Med posters will present data on NimbuDerm™, the company’s
persistent hand sanitizer technology, and Stay Fresh™, a new highly durable textiles
technology that is especially well suited for health care applications:
Hand Sanitizer Technology and Progress Toward a more Functional Concept –
Achievement of sustained antimicrobial protection exceeding six hours via the
development of a high performance, breathable skin sanitizer coating which is a barrier to
adventitious contamination.
Medical Textile Fabric as a Barrier to Pathogen Transmission – A profile of the high
performance, high durability properties of Quick-Med’s Stay Fresh™ textiles technology.
This novel antimicrobial treatment achieves 99.999% kill performance against both
Gram-positive and Gram-negative bacteria that is sustained through more than 50
laundering cycles, outperforming available antimicrobial treatments for healthcare
uniforms and scrubs, patient bed linens, and other medical textile fabric applications.
About the Symposium on Advanced Wound Care/Wound Healing Society Meeting
The 22nd Annual SAWC/WHS Meeting is the premier educational wound care program
within this clinical field and is the largest annual gathering of wound care clinicians in
the United States. More than 2000 physicians, podiatrists, nurses, therapists, and
researchers are expected to attend.
About NIMBUS
NIMBUS poses no danger of bacteria developing resistance, or of releasing toxic
material into the wound and impeding the wound healing process. It is a novel
antimicrobial technology: bonded and effective even in high concentrations of body
fluids.
|
